Strong Top-Line Growth
Q1 revenue of $26.5M, up 25% year-over-year; U.S. revenue $21.4M (+25% YoY) and international revenue $5.2M (+23% YoY).
Improved Profitability Metrics
Gross profit of $18.3M, up 37% YoY; gross margin increased to 69% from 63% (a +6 percentage-point increase, ~+9% relative improvement).
Adjusted EBITDA and Cash Improvement
Adjusted EBITDA loss improved to $6.1M vs. $9.1M prior year (32% improvement). Cash & cash equivalents $138M; quarterly cash use $12.5M, an improvement of $2.2M (15%) versus prior-year quarter.
Embedded Business Acceleration
Butterfly Embedded revenue $5.7M, up 147% YoY, primarily driven by the Midjourney partnership; Embedded now a material and growing revenue engine.
POCUS Hardware Mix Driving Higher ASPs
Probe unit sales up 5% in the quarter; mix shift to higher-end iQ3 drove an 11% year-over-year improvement in average selling price. iQ3 sales +39% YoY.
AI & Regulatory Milestone — GA Blind Sweep Clearance
First-ever FDA clearance of a blind-sweep gestational age (GA) AI tool (2-minute fetal age estimation), trained on ~21 million images; FDA publicly highlighted the clearance.
Ecosystem & Software Momentum
Butterfly Garden expanded to 30 partners (2 new this quarter); four partners have received FDA clearances; Compass AI pipeline up sharply YoY, closed first enterprise deal this quarter including a 7-figure software total contract value (TCV).
Education & Enterprise Traction
Nearly 1,000 probes sold so far this year to medical school programs across six institutions, and initial enterprise Compass AI adoption underway with expectations of growing enterprise revenue in 2026.
Security & Federal Readiness
Achieved HITRUST r2 certification and entry into the FedRAMP marketplace process (VA sponsorship), enhancing ability to pursue large health systems and federal opportunities.
Product & Platform Roadmap
Apollo chip and Embedded roadmap highlighted as future revenue catalysts; ninth Embedded partner signed, multiple additional partners expected; new probe planned early next year (harmonics with CMA) and a station targeted in early-mid 2027.
Home and Community Care Progress
Butterfly Home & Community Care planning first commercial agreement in H1 2026 with initial statewide deployment and nurse training in Q3; expectation of revenue contribution in H2 2026 and expansion in 2027.